We are live on ! Find out more
EEG

E.E. Geduld Portfolio holdings

AUM $178M
1-Year Est. Return 29.34%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$185M
AUM Growth
-$21.9M
Cap. Flow
+$579K
Cap. Flow %
0.31%
Top 10 Hldgs %
38.04%
Holding
415
New
80
Increased
38
Reduced
43
Closed
102

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$4.64M
2
LNN icon
Lindsay Corp
LNN
+$2.12M
3
MNDT
Mandiant, Inc. Common Stock
MNDT
+$1.77M
4
BSX icon
Boston Scientific
BSX
+$1.51M
5
VZ icon
Verizon
VZ
+$1.42M

Top Sells

Rank Stock Value
1
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$4.34M
2
DDD icon
3D Systems Corp
DDD
+$1.86M
3
LEN icon
Lennar Class A
LEN
+$989K
4
BB icon
BlackBerry
BB
+$938K
5
VNCE icon
Vince Holding Corp
VNCE
+$928K

Sector Composition

Rank Sector Weight
1 Financials 31.91%
2 Miscellaneous 27.85%
3 Healthcare 13.47%
4 Technology 9.49%
5 Consumer Discretionary 3.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BURL icon
101
Burlington
BURL
$18.3B
$443K 0.24%
15,000
-10,000
-40% -$275K
INCY icon
102
Incyte
INCY
$25.9B
$428K 0.23%
8,000
-2,500
-24% -$155K
PRMW
103
CALL
DELISTED
Primo Water Corporation
PRMW
$424K 0.23%
+50,000
New +$403K
FIO
104
DELISTED
FUSION-IO INC COM
FIO
$421K 0.23%
+40,000
New +$423K
MCHX icon
105
Marchex
MCHX
$80.3M
$420K 0.23%
+40,000
New +$423K
OTE
106
DELISTED
HELLENIC TELECOMM ORG ADS(RP1/
OTE
$414K 0.22%
50,000
– –
GRFS
107
Grifois
GRFS
$5.32B
$413K 0.22%
20,000
+5,714
+40% +$114K
BV
108
DELISTED
Bazaarvoice, Inc.
BV
$402K 0.22%
+55,000
New +$416K
ACAS
109
DELISTED
American Capital Ltd
ACAS
$395K 0.21%
+25,000
New +$385K
PCH
110
DELISTED
PotlatchDeltic
PCH
$387K 0.21%
10,000
– –
NVAX icon
111
Novavax
NVAX
$1.49B
$385K 0.21%
4,250
-750
-15% -$83.8K
RH icon
112
RH
RH
$2.74B
$368K 0.2%
5,000
-7,500
-60% -$468K
ITCI
113
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$364K 0.2%
+20,030
New +$362K
AVHI
114
DELISTED
A V Homes, Inc.
AVHI
$362K 0.2%
20,000
– –
JMP
115
DELISTED
JMP Group LLC
JMP
$356K 0.19%
50,000
– –
CVA
116
CALL
DELISTED
Covanta Holding Corporation
CVA
$350K 0.19%
+19,400
New +$343K
DD
117
DELISTED
Du Pont De Nemours E I
DD
$349K 0.19%
+5,476
New +$335K
HRTX icon
118
Heron Therapeutics
HRTX
$63M
$348K 0.19%
25,000
– –
PRSO icon
119
Peraso
PRSO
$9.83M
$341K 0.18%
9
– –
JEF icon
120
Jefferies Financial Group
JEF
$12.2B
$340K 0.18%
13,573
– –
CTIC
121
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$340K 0.18%
10,000
+5,000
+100% +$171K
TNK icon
122
Teekay Tankers
TNK
$3.06B
$336K 0.18%
+11,875
New +$372K
CSOD
123
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$335K 0.18%
+7,000
New +$391K
EL icon
124
Estee Lauder
EL
$38.4B
$334K 0.18%
+5,000
New +$347K
ADEP
125
DELISTED
Adept Technology Inc
ADEP
$333K 0.18%
+17,500
New +$301K
3 4
5
6 7

Similar funds

BC
Bocage Capital San Francisco, California $185M AUM 61.49% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $169M AUM 8.84% 1-Year Est. Return
SRP
Saddle Road Partners Omaha, Nebraska $197M AUM 13.19% 1-Year Est. Return
CF
CenterStar Fund Chicago, Illinois $159M AUM 13.43% 1-Year Est. Return
SA
Steadfast Advisors New York $204M AUM 28.42% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
SIG
Stanford Investment Group Mountain View, California $205M AUM 7.44% 1-Year Est. Return
VWM
Vector Wealth Management Minneapolis, Minnesota $142M AUM 10.42% 1-Year Est. Return

E.E. Geduld's Q1 2014 Portfolio in Review

As of Q1 2014, E.E. Geduld held 415 positions worth $185M, down 11% from $207M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

E.E. Geduld's Q1 2014 filing shows 80 new, 38 increased, 43 reduced and 102 closed positions. Its largest new stake was Johnson & Johnson: 50,000 shares worth $4.91M. The largest sale was Ariad Pharmaceuticals Inc, an estimated $4.34M.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Healthcare.

  • E.E. Geduld's largest Q1 2014 buy was Johnson & Johnson: 50,000 shares worth $4.91M.
  • E.E. Geduld added most to Boston Scientific in Q1 2014, an estimated $1.51M increase.
  • E.E. Geduld's biggest Q1 2014 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $4.34M.
  • E.E. Geduld fully exited 3D Systems Corp in Q1 2014, selling an estimated $1.86M.
  • E.E. Geduld's ten largest holdings make up 38% of its $185M portfolio in Q1 2014.
  • E.E. Geduld opened 80 new positions and closed 102 in Q1 2014.
  • E.E. Geduld's portfolio value fell 11% quarter-over-quarter to $185M.

Based on E.E. Geduld's 13F filing for Q1 2014, filed 7 May 2014.